B 
Beijing Bohui Innovation Biotechnology Group Co 300318.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
4.45
-1.33%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥824.6m
FY2016FY2025
Net income
−CN¥91.9m
FY2016FY2025
Free cash flow
−CN¥292.1m
FY2016FY2025
Shareholders' equity
CN¥1.29bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥824.6m | CN¥851.7m | CN¥1.05bn | CN¥795.9m | CN¥714.7m | CN¥738.7m | CN¥628.3m | CN¥622.1m | CN¥443.8m | CN¥404.0m |
| Gross profit | CN¥326.2m | CN¥417.5m | CN¥451.5m | CN¥253.5m | CN¥292.5m | CN¥353.2m | CN¥303.9m | CN¥312.1m | CN¥234.3m | CN¥214.4m |
| Research and development | CN¥64.9m | CN¥52.5m | CN¥69.2m | CN¥64.8m | CN¥81.5m | CN¥48.2m | CN¥46.6m | CN¥53.5m | CN¥48.5m | CN¥40.5m |
| Operating income | CN¥6.9m | CN¥35.2m | CN¥33.8m | −CN¥91.1m | −CN¥458.3m | CN¥37.2m | CN¥53.1m | CN¥107.6m | CN¥99.6m | CN¥49.6m |
| Net income | −CN¥91.9m | CN¥9.2m | −CN¥24.9m | −CN¥78.4m | −CN¥322.2m | CN¥7.5m | CN¥2.5m | CN¥69.4m | CN¥38.9m | CN¥23.6m |
| Diluted earnings per share | -0.11 | 0.01 | -0.03 | -0.10 | -0.40 | 0.01 | 0.00 | 0.08 | 0.05 | 0.03 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥4.30bn | CN¥4.13bn | CN¥3.93bn | CN¥3.91bn | CN¥3.69bn | CN¥3.72bn | CN¥2.69bn | CN¥2.71bn | CN¥2.74bn | CN¥2.09bn |
| Cash and short-term investments | — | CN¥77.3m | CN¥104.9m | CN¥113.6m | CN¥39.4m | CN¥44.6m | CN¥30.1m | CN¥102.5m | CN¥67.3m | CN¥46.1m |
| Total liabilities | CN¥2.13bn | CN¥1.78bn | CN¥1.59bn | CN¥1.58bn | CN¥2.76bn | CN¥2.28bn | CN¥1.64bn | CN¥1.47bn | CN¥1.12bn | CN¥569.9m |
| Debt | CN¥437.0m | CN¥880.1m | CN¥745.9m | CN¥789.3m | CN¥554.6m | CN¥616.3m | CN¥611.9m | CN¥331.9m | CN¥278.8m | CN¥45.4m |
| Shareholders' equity | CN¥1.29bn | CN¥1.38bn | CN¥1.37bn | CN¥1.39bn | CN¥974.8m | CN¥1.30bn | CN¥1.03bn | CN¥1.17bn | CN¥1.47bn | CN¥1.42bn |
| Shares outstanding | 822m | 819m | 818m | 816m | 815m | 822m | 845m | 822m | 817m | 824m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −CN¥135.2m | −CN¥38.7m | CN¥137.0m | CN¥40.7m | CN¥887,777 | CN¥86.1m | −CN¥36.0m | −CN¥84.1m | −CN¥95.2m | CN¥78.0m |
| Capital spending | −CN¥156.9m | −CN¥189.0m | −CN¥197.5m | −CN¥161.5m | −CN¥367.1m | −CN¥202.3m | −CN¥108.9m | −CN¥53.3m | −CN¥39.6m | −CN¥37.4m |
| Free cash flow | −CN¥292.1m | −CN¥227.6m | −CN¥60.5m | −CN¥120.7m | −CN¥366.2m | −CN¥116.2m | −CN¥144.9m | −CN¥137.4m | −CN¥134.7m | CN¥40.6m |
| Dividends paid | −CN¥31.4m | −CN¥32.7m | −CN¥51.1m | −CN¥26.7m | −CN¥25.9m | −CN¥27.3m | −CN¥29.5m | −CN¥16.7m | −CN¥12.5m | −CN¥2.9m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥205.7m | CN¥189.9m | CN¥195.8m | CN¥224.8m | CN¥202.3m | CN¥201.7m | CN¥205.6m | CN¥159.2m |
| Gross profit | CN¥73.2m | CN¥56.4m | CN¥78.9m | CN¥88.4m | CN¥81.5m | CN¥77.4m | CN¥90.3m | CN¥79.1m |
| Operating income | −CN¥3.1m | −CN¥7.4m | −CN¥13.8m | CN¥3.7m | −CN¥21.8m | CN¥10.9m | −CN¥31.7m | CN¥1.4m |
| Net income | −CN¥8.3m | −CN¥7.3m | −CN¥58.3m | −CN¥14.9m | −CN¥14.6m | −CN¥4.1m | −CN¥14.5m | −CN¥3.9m |
| Diluted earnings per share | -0.01 | -0.01 | -0.07 | -0.02 | -0.02 | -0.00 | -0.02 | -0.00 |
| Cash from operations | — | — | — | −CN¥62.0m | −CN¥21.0m | −CN¥29.0m | — | −CN¥29.0m |
| Capital spending | −CN¥26.0m | −CN¥27.0m | −CN¥36.0m | −CN¥36.0m | −CN¥50.0m | −CN¥32.0m | −CN¥36.0m | −CN¥44.0m |
| Free cash flow | — | — | — | −CN¥98.0m | −CN¥71.0m | −CN¥61.0m | — | −CN¥73.0m |
| Total assets | CN¥4.39bn | CN¥4.36bn | CN¥4.30bn | CN¥4.33bn | CN¥4.32bn | CN¥4.38bn | CN¥4.13bn | CN¥4.12bn |
| Cash and short-term investments | — | — | — | CN¥100.5m | CN¥169.0m | CN¥286.8m | CN¥77.3m | CN¥118.4m |
| Debt | CN¥367.2m | CN¥444.1m | CN¥437.0m | CN¥580.0m | CN¥1.05bn | CN¥1.17bn | CN¥841.8m | CN¥902.1m |
| Shareholders' equity | CN¥1.27bn | CN¥1.28bn | CN¥1.29bn | CN¥1.35bn | CN¥1.36bn | CN¥1.37bn | CN¥1.38bn | CN¥1.39bn |
Financial ratios
Data as of 16 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 39.6% | 49.0% | 43.2% | 31.9% | 40.9% | 47.8% |
| Operating margin | -16.7% | 5.8% | 5.9% | -11.4% | -64.1% | 5.0% |
| Net margin | -11.1% | 1.1% | -2.4% | -9.9% | -45.1% | 1.0% |
| Return on equity | -7.2% | 0.7% | -1.8% | -5.6% | -33.1% | 0.6% |
| Return on assets | -2.1% | 0.2% | -0.6% | -2.0% | -8.7% | 0.2% |
| Free cash flow yield | 0.5% | 3.8% | 8.4% | 5.1% | 9.3% | 7.2% |
| Revenue growth | -3.2% | -18.5% | 31.3% | 11.4% | -3.2% | 17.6% |
| Earnings growth | -1094.2% | -137.1% | -68.2% | -75.7% | -4393.4% | 195.1% |
| Current ratio | 0.93x | 1.01x | 1.06x | 1.02x | 0.43x | 0.54x |
| Debt to equity | 0.34x | 0.61x | 0.52x | 0.53x | 0.53x | 0.41x |
| Equity ratio | 29.9% | 33.4% | 34.9% | 35.7% | 26.4% | 35.0% |
| Interest coverage | -4.12x | 1.67x | 2.14x | -2.10x | -9.99x | 1.02x |
| R&D as a share of sales | 7.9% | 6.2% | 6.6% | 8.1% | 11.4% | 6.5% |
| Buybacks as a share of market value | -0.3% | -0.2% | -0.2% | -0.2% | 0.9% | 2.7% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 1.2% | 2.2% | 11.9% |
| Operating income | — | -28.5% | -4.4% |
| Net income | 5.4% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 44.4% | 41.2% | 42.1% | 44.8% |
| Operating margin | 2.5% | -0.4% | -8.8% | -1.6% |
| Net margin | -4.9% | -5.3% | -10.1% | -4.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -56.0 | — | -204.7 | -60.9 | -25.1 | — | — | 47.1 | 113.6 | 316.4 |
| Price to sales | 6.3 | 5.5 | 4.9 | 6.0 | 11.3 | 13.3 | 5.5 | 5.3 | 9.9 | 18.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 12 Jul 2018.
| FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.005 | 0.003 | 0.001 | 0.005 | 0.018 | 0.016 |
- 1.992-for-1 split · 21 Jun 2016
- 2-for-1 split · 21 Jul 2015
- 8-for-5 split · 3 Jun 2013
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.